SynthesisBMC cancer2024

CDK4/6 inhibitors plus endocrine therapy vs. placebo plus endocrine therapy for HR+/HER2- advanced breast cancer: a phase III RCTs based meta-analysis.

Cailu Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.